Publications - Page 36 sur 43 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Hypertension pulmonaire (HTP) 02/08/23
PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic

Godinas L, Iyer K, Meszaros G, Quarck R, Escribano-Subias P, Vonk Noordegraaf A, Jansa P, D’Alto M, Luknar M, Milutinov Ilic S, Belge C, Sitbon O, Reis A, Rosenkranz S, Pepke-Zaba J, Humbert M, Delcroix M.

Orphanet J Rare Dis. 2021 May 1;16(1):196. Doi: 10.1186/s13023-021-01752-1.
Hypertension pulmonaire (HTP) 02/08/23
Inhaled Treprostinil in Group 3 Pulmonary Hypertension

Nasser M, Kolb M, Cottin V.

N Engl J Med. 2021 May 13;384(19):1869. Doi: 10.1056/NEJMc2103465.
Hypertension pulmonaire (HTP) 02/08/23
Additive protective effects of sacubitril/valsartan and bosentan on vascular remodelling in experimental pulmonary hypertension

Chaumais MC, Djessas MRA, Thuillet R, Cumont A, Tu L, Hebert G, Gaignard P, Huertas A, Savale L, Humbert M, Guignabert C.

Cardiovasc Res. 2021 Apr 23;117(5):1391-1401. Doi: 10.1093/cvr/cvaa200.
Hypertension pulmonaire (HTP) 02/08/23
Transplantation for pulmonary arterial hypertension with congenital heart disease: Impact on outcomes of the current therapeutic approach including a high-priority allocation program

Hascoët S, Pontailler M, Le Pavec J, Savale L, Mercier O, Fabre D, Mussot S, Simonneau G, Jais X, Feuillet S, Stephan F, Cohen S, Bonnet D, Humbert M, Dartevelle P, Fadel E.

Am J Transplant. 2021 Apr 12. Doi: 10.1111/ajt.16600.
Hypertension pulmonaire (HTP) 02/08/23
Sotatercept for the Treatment of Pulmonary Arterial Hypertension

Humbert M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, Souza R, Waxman A, Escribano Subias P, Feldman J, Meyer G, Montani D, Olsson KM, Manimaran S, Barnes J, Linde PG, de Oliveira Pena J, Badesch DB; PULSAR Trial Investigators.

N Engl J Med. 2021 Apr 1;384(13):1204-1215. Doi: 10.1056/NEJMoa2024277.
Hypertension pulmonaire (HTP) 02/08/23
Preoperative C-reactive protein predicts early postoperative outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension

Arthur Ataam J, Amsallem M, Guihaire J, Haddad F, Lamrani L, Stephan F, Jaïs X, Humbert M, Mercier O, Fadel E.

J Thorac Cardiovasc Surg. 2021 Apr;161(4):1532-1542.e5. Doi: 10.1016/j.jtcvs.2019.11.133.
Hypertension pulmonaire (HTP) 02/08/23
Hypoxemia during sleep and overnight rostral fluid shift in pulmonary arterial hypertension : a pilot study

Jutant EM, Montani D, Sattler C, Günther S, Sitbon O, Garcia G, Arnulf I, Humbert M, Similowski T, Redolfi S.

Pulm Circ. 2021 Mar 30;11(2):2045894021996930. Doi: 10.1177/2045894021996930.
Hypertension pulmonaire (HTP) 02/08/23
An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension

Ryanto GRT, Ikeda K, Miyagawa K, Tu L, Guignabert C, Humbert M, Fujiyama T, Yanagisawa M, Hirata KI, Emoto N.

Nat Commun. 2021 Mar 19;12(1):1720. Doi: 10.1038/s41467-021-21961-3.
Hypertension pulmonaire (HTP) 02/08/23
Risk Stratification in Pulmonary Arterial Hypertension : Do Not Forget the Patient Perspective

Humbert M, Lau EMT

Am J Respir Crit Care Med. 2021 Mar 15;203(6):675-677. Doi: 10.1164/rccm.202012-4350ED.
Hypertension pulmonaire (HTP) 02/08/23
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

Ghofrani HA, Gomez Sanchez MA, Humbert M, Pittrow D, Simonneau G, Gall H, Grünig E, Klose H, Halank M, Langleben D, Snijder RJ, Escribano Subias P, Mielniczuk LM, Lange TJ, Vachiéry JL, Wirtz H, Helmersen DS, Tsangaris I, Barberá JA, Pepke-Zaba J, Boonstra A, Rosenkranz S, Ulrich S, Steringer-Mascherbauer R, Delcroix M, Jansa P, Šimková I, Giannakoulas G, Klotsche J, Williams E, Meier C, Hoeper MM; NEW COLLABORATORS LIST.

Respir Med. 2021 Mar;178:106220. Doi: 10.1016/j.rmed.2020.106220.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic

Inhaled Treprostinil in Group 3 Pulmonary Hypertension

Additive protective effects of sacubitril/valsartan and bosentan on vascular remodelling in experimental pulmonary hypertension

Transplantation for pulmonary arterial hypertension with congenital heart disease: Impact on outcomes of the current therapeutic approach including a high-priority allocation program

Sotatercept for the Treatment of Pulmonary Arterial Hypertension

Preoperative C-reactive protein predicts early postoperative outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension

Hypoxemia during sleep and overnight rostral fluid shift in pulmonary arterial hypertension : a pilot study

An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension

Risk Stratification in Pulmonary Arterial Hypertension : Do Not Forget the Patient Perspective

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry